150 related articles for article (PubMed ID: 2358843)
1. Combined modality therapy in esophageal cancer.
Einhorn LH
J Clin Oncol; 1990 Jul; 8(7):1286-7. PubMed ID: 2358843
[No Abstract] [Full Text] [Related]
2. Esophagogastric cancer--time to change the paradigm.
O'Sullivan GC; Shanahan F
Am J Gastroenterol; 2000 Sep; 95(9):2153-4. PubMed ID: 11007209
[No Abstract] [Full Text] [Related]
3. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
Theisen J; Siewert JR
MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
[No Abstract] [Full Text] [Related]
4. Esophageal carcinoma: impact of staging on treatment.
Siewert JR; Dittler HJ
Endoscopy; 1993 Jan; 25(1):28-32. PubMed ID: 8453923
[No Abstract] [Full Text] [Related]
5. Treatment strategies for esophageal cancer.
Nieman DR; Peters JH
Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
[TBL] [Abstract][Full Text] [Related]
6. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
[No Abstract] [Full Text] [Related]
7. Management of esophageal cancer.
Coia L; Engstrom P; Paul A; Hanks G
J Clin Oncol; 1990 Jul; 8(7):1285-6. PubMed ID: 2358842
[No Abstract] [Full Text] [Related]
8. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
[TBL] [Abstract][Full Text] [Related]
9. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
[TBL] [Abstract][Full Text] [Related]
10. Esophageal cancers: changing character, increasing incidence.
McCann J
J Natl Cancer Inst; 1999 Mar; 91(6):497-8. PubMed ID: 10088616
[No Abstract] [Full Text] [Related]
11. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
12. Management of carcinoma of the esophagus.
Seibert DG; Hill RC
W V Med J; 1989 Feb; 85(2):53-7. PubMed ID: 2464245
[TBL] [Abstract][Full Text] [Related]
13. Section II: pathology and pathologic staging of esophageal cancer.
Glickman JN
Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):167-79. PubMed ID: 12838487
[TBL] [Abstract][Full Text] [Related]
14. Multimodal therapy for esophageal adenocarcinoma.
Badwe RA; Vaidya JS; Bhansali MS
N Engl J Med; 1997 Jan; 336(5):374-5; author reply 375-6. PubMed ID: 9011794
[No Abstract] [Full Text] [Related]
15. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
Brown RE; Abbas AE; Ellis S; Williams S; Scoggins CR; McMasters KM; Martin RC
J Am Coll Surg; 2011 Apr; 212(4):582-8; discussion 588-9. PubMed ID: 21463793
[TBL] [Abstract][Full Text] [Related]
16. Esophageal cancer. Clinical and pathologic features.
Gore RM
Radiol Clin North Am; 1997 Mar; 35(2):243-63. PubMed ID: 9087202
[TBL] [Abstract][Full Text] [Related]
17. Primary oesophageal carcinoma in teens.
Kumar A; Shukla NK; Mishra MC; Shahi UP; Kapur BM
J Surg Oncol; 1992 Aug; 50(4):254-7. PubMed ID: 1640711
[TBL] [Abstract][Full Text] [Related]
18. [Residual esophageal cancer after neoadjuvant chemoradiotherapy: frequently the mucosa and submucosa are involved].
Brink F; Jähne J
Chirurg; 2014 Mar; 85(3):257. PubMed ID: 24519613
[No Abstract] [Full Text] [Related]
19. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
20. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.
Eloubeidi MA; Wallace MB
Gastrointest Endosc; 2001 Jul; 54(1):132-4. PubMed ID: 11447984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
